Danaher Corp

1. 1

   Election of Directors

   ManagementBoard: FOR

   Elect eleven director nominees to hold office until the 2027 Annual Meeting and until their successors are elected and qualified.

2. 2

   Ratification of Independent Registered Public Accounting Firm

   ManagementBoard: FOR

   Ratify the Audit Committee’s selection of Ernst & Young LLP as Danaher’s independent registered public accounting firm for 2026.

3. 3

   Advisory Vote to Approve Named Executive Officer Compensation (Say-on-Pay

   ManagementBoard: FOR

   Non‑binding, advisory vote to approve the compensation disclosed for the Company’s named executive officers, including the Compensation Discussion and Analysis and compensation tables.

   More detail

   This proposal asks shareholders to cast a non‑binding advisory vote approving the Company’s disclosed named executive officer (NEO) compensation as presented in the proxy, including the Compensation Discussion and Analysis, compensation tables and narrative. Management seeks this advisory endorsement to confirm shareholder support for pay design and outcomes and to inform future compensation decisions; the Compensation Committee will consider voting results when setting future pay. The proxy discloses that Danaher’s program emphasizes long‑term, performance‑based equity, multi‑year vesting and stringent clawback policies, and that 2026 program changes were made to better align incentive metrics with Danaher’s evolving life‑science and diagnostics strategy (e.g., shifting metrics between annual and long‑term plans, adding time‑vested RSUs, changing PSU weighting and comparator group). The filing highlights strong shareholder engagement (contacting holders of ~50% of shares and engaging with ~20%) and that the 2025 say‑on‑pay received 93% support, which management cites as evidence of alignment. Key governance features include an independent compensation consultant, stock ownership requirements, no hedging/pledging, and discretionary committee authority to adjust awards. Economically, the program ties a large portion of pay to relative TSR‑based PSUs (with ROIC modifier) and multi‑year holding periods, while annual cash incentives use Adjusted EPS, Free Cash Flow Ratio and Core Revenue Growth; 2026 refinements shift emphasis to adjusted operating income and other measures to sharpen accountability. In recommending a FOR vote, the Board argues these elements promote long‑term shareholder value, retention and appropriate risk management while preserving Committee discretion to respond to changing circumstances. Institutional investors should evaluate the non‑binding recommendation in light of these programmatic changes, recent performance outcomes, and the company’s disclosures on target setting, peer group composition, and clawback provisions.

4. 4

   Approval of Amended and Restated Danaher Corporation Omnibus Incentive Plan

   ManagementBoard: FOR

   Approve amendments to the Omnibus Incentive Plan to increase the share reserve by 20 million shares and extend the plan term to May 5, 2036 so the Company can continue granting equity awards.

   More detail

   This management proposal requests shareholder approval to amend and restate Danaher’s Omnibus Incentive Plan to add 20 million shares to the reserve and extend the plan term to May 5, 2036. Management frames the request as routine and necessary to ensure sufficient shares are available to grant equity awards that attract, retain and incentivize employees and directors and align their interests with shareholders. The filing provides supporting metrics: a 2025 burn rate of 0.42%, a 2023–2025 average burn rate of 0.43%, and an actual overhang of 8.30% (pro‑forma 10.60% including the requested shares), positions the company near peer norms and argues the additional reserve should support grants through approximately 2033 assuming typical grant practices and stock price behavior. The Plan contains standard corporate governance features (minimum one‑year vesting for most awards with limited exceptions, per‑participant caps, anti‑recycling provisions, adjustment and anti‑dilution rules, and robust clawback provisions), and management notes it is not seeking other substantive changes. From a governance perspective, investors should review the incremental dilution versus the company’s historical usage, the per‑participant limits, fungible counting rules (full‑value awards count as 3.56 shares post‑2017), and the board’s rationale that the reserve is prudent given Danaher’s acquisition activity and need for long‑term incentives. The Committee’s recommendation is supported by peer‑relative metrics and an expectation that equity awards will remain a primary retention and pay‑for‑performance tool; institutional investors will weigh the incremental dilution against dilution management’s framing and long‑term shareholder alignment features when deciding whether to support the amendment.

Upcoming shareholder meetings at Danaher Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.

When is the Danaher Corp 2026 annual meeting?

Danaher Corp (DHR) holds its 2026 annual shareholder meeting on Tuesday, May 5, 2026.

What is the record date for the Danaher Corp 2026 meeting?

The record date for the Danaher Corp 2026 meeting is Friday, March 6, 2026. Shareholders of record on or before that date are eligible to vote.

Who are the director nominees for Danaher Corp's 2026 meeting?

The board is presenting 11 director nominees at the Danaher Corp 2026 meeting, listed with their independence status and background.

What proposals will shareholders vote on at the Danaher Corp 2026 meeting?

Shareholders will vote on 4 proposals at the Danaher Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.